Standard clinical guidelines require starting at 0.25mg weekly for Month 1, stepping up to 0.5mg for Month 2, 1.0mg for Month 3, 1.7mg for Month 4, and reaching the 2.4mg therapeutic maintenance dose in Month 5.
2. Mitigating Gastrointestinal Adaptation
Gradual titration allows the gut-brain axis to adjust to slower stomach motility. Patients who adhere to the 4-week step ladder experience 70% fewer nausea symptoms compared to rushed dosing.
3. Zero Price Increases as Doses Escalate
While other providers increase their monthly rates by $100 for every step up in dose, our partner's $79/mo flat rate remains 100% fixed through all titration levels.
Frequently Asked Clinical Questions
The 0.25mg dose is a non-therapeutic introductory dose designed specifically to acclimate your body to GLP-1 receptor signaling while preventing acute gastrointestinal distress.
Yes. If you are experiencing steady weight loss of 1 to 2 lbs per week and good appetite suppression at 0.5mg or 1.0mg, your physician can keep you at that dosage level indefinitely.
Mild nausea is common for 24-48 hours after dose escalation. Staying hydrated, eating smaller protein-rich meals, and avoiding high-fat or greasy foods typically resolves symptoms rapidly.
Clinical trials demonstrate that patients can safely maintain therapeutic Semaglutide treatment long-term to preserve healthy metabolic function and prevent weight rebound.